Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
49,662,791
-
Shares change
-
-447,701
-
Total reported value, excl. options
-
$627,746,190
-
Value change
-
-$7,334,893
-
Number of buys
-
14
-
Number of sells
-
-14
-
Price
-
$12.64
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q4 2017
40 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q4 2017.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,662,791 shares
.
Largest 10 shareholders include QVT Financial LP (37,231,342 shares), BB BIOTECH AG (3,507,882 shares), RA CAPITAL MANAGEMENT, LLC (2,830,455 shares), NovaQuest Capital Management, L.L.C. (1,188,361 shares), BlackRock Inc. (1,016,921 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (870,000 shares), NORGES BANK (600,000 shares), EVENTIDE ASSET MANAGEMENT, LLC (552,100 shares), Tekla Capital Management LLC (400,000 shares), and D. E. Shaw & Co., Inc. (350,000 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.